TESARO Announces Participation at Three Investor Conferences

WALTHAM, Mass., April 22, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq: TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three investor conferences during the month of May, including:

• The Mizuho Securities USA Third Annual Healthcare Corporate Access Day in New York City on Tuesday, May 5, 2015;
• The Citi Midwest Healthcare Access Day in Chicago on Tuesday, May 5, 2015; and
• The Deutsche Bank 40th Annual Health Care Conference at the Intercontinental Hotel in Boston, May 6-7, 2015. Lonnie Moulder, CEO, and Mary Lynne Hedley, Ph.D., President and COO of TESARO, are scheduled to present an overview of TESARO's business and development programs at 2:10 PM ET on Thursday, May 7. A live webcast will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. An archived replay of the webcast will be available on the Company's website for 14 days after the conference.

About TESARO

TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

CONTACT: For additional information, please contact:
         Jennifer Davis
         1.781.325.1116
         [email protected]

You May Also Be Interested In

• Deutsche Bank Upgrades Target Hospitality (TH) to Buy
• U.S. Recall Volume Exceeds One Billion Units in 2026
• JCET Reports 79.4% YoY Growth in H1 2026 Net Profit Attributable to Shareholders, Accelerates Advanced Packaging Expansion